The target tissue in autoimmunity – an influential niche

European Journal of Immunology - Tập 37 Số 3 - Trang 589-597 - 2007
Natasha Hill1, Monica Hultcrantz2, Nora Sarvetnick3, Malin Flodström‐Tullberg2
1Centre for Diabetes and Metabolic Medicine, Institute of Cell and Molecular Sciences, Barts and the London Queen Mary's School of Medicine and Dentistry, London, UK
2Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
3The Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA

Tóm tắt

AbstractCentral and peripheral tolerance mechanisms were for a long time the only regulatory circuits known in autoimmunity. It is now becoming clear that the target tissue itself may have the capacity to control its own destiny. Here we review mechanisms by which the target tissue regulates local inflammation, and the way this could influence progression to overt autoimmunity. Moreover, we discuss recent data showing that physiological properties of the target tissue can determine the organ specificity of autoimmune disease. These recent discoveries and ideas concerning the regulatory potential of the target tissue may, in the future, add a new dimension to our concept of regulatory circuits in autoimmunity.

Từ khóa


Tài liệu tham khảo

10.1586/14737175.6.5.781

10.1016/j.coi.2006.06.004

10.1146/annurev.iy.13.040195.001143

10.1038/nm1176

10.1172/JCI28349

10.1038/ni1012

10.2337/diabetes.52.11.2696

10.4049/jimmunol.172.9.5714

10.1056/NEJMra052723

10.1007/s00125-002-1017-0

10.1007/s001250051622

10.1038/nm1202-792

10.1038/ni1372

10.1002/art.10860

Groom J., 2002, Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome., J. Clin. Invest., 109, 59, 10.1172/JCI0214121

10.1084/jem.20041674

10.1016/j.pharmthera.2006.06.002

10.1016/j.coph.2004.04.003

10.1053/gast.2000.18149

10.1016/S0016-5085(03)01047-3

10.1016/S0165-5728(01)00401-5

10.1073/pnas.1131954100

10.2337/diabetes.45.6.779

10.1111/j.1399-0039.1997.tb02854.x

10.1038/35021081

10.2337/db06-0109

10.1038/nri1199

10.1016/j.immuni.2004.06.020

10.1016/j.immuni.2004.06.018

10.1073/pnas.1632807100

10.1016/j.immuni.2004.05.008

10.1084/jem.20022125

10.1002/eji.200324228

10.1084/jem.20051776

10.1038/nm1402

10.2337/db05-1673

10.1126/science.290.5497.1768

10.1111/j.0022-202X.2004.23461.x

10.1080/09273940490895326

10.1016/S0002-9440(10)64444-6

10.1016/S1471-4906(02)02223-8

10.1189/jlb.0705398

10.1189/jlb.1102535

10.1126/science.1075958

10.1111/j.0105-2896.2005.00231.x

10.1038/nature01621

10.1016/j.smim.2006.03.008

10.1084/jem.181.3.1123

10.1073/pnas.98.1.235

10.1016/j.clim.2005.10.006

10.1016/j.biocel.2005.08.019

10.1038/ni771

10.2337/diabetes.52.8.2025

10.1172/JCI16491

10.1038/ni1306

10.1002/art.10898

10.1093/rheumatology/keg271

10.1038/ni775

10.1038/ni772

10.1073/pnas.182549099

10.1186/ar395

10.1186/ar95

10.1016/j.biocel.2006.03.008

10.1016/j.autrev.2005.09.006

10.2741/1506

10.1038/nri885

10.1016/j.freeradbiomed.2006.05.020

10.1007/978-1-4615-0065-0_5

10.2741/1795

10.1093/rheumatology/kel023

10.1016/S0165-5728(98)00002-2

10.1172/JCI5150

10.1016/S0002-9440(10)65249-2

10.1046/j.1365-3083.2002.01058.x

Garcia‐Lopez M. A., 2001, Thyrocytes from autoimmune thyroid disorders produce the chemokines IP‐10 and Mig and attract CXCR3+ lymphocytes., J. Clin. Endocrinol. Metab., 86, 5008, 10.1210/jcem.86.10.7953

10.1016/S0140-6736(87)91128-7

10.1002/art.21140

10.4049/jimmunol.174.2.864

10.1186/1745-6150-2-5